Richard advises clients on all aspects of intellectual property litigation, including patent, copyright, trademark, and trade secret litigation and related antitrust and unfair competition matters. He has represented numerous Fortune 100 companies in intellectual property infringement cases nationwide.
A registered patent attorney, Richard regularly counsels companies in the development and protection of their intellectual property portfolios, with a particular emphasis on computer software, medical devices and diagnostics, and he provides advice on intellectual property strategy in general. He also provides patentability, non-infringement, and invalidity opinions in a variety of technology areas and serves on Mintz Levin's Opinion Committee.
Richard has extensive experience performing intellectual property audits and due diligence for high tech and life sciences companies and investors in connection with various commercial transactions, including mergers and acquisitions, private placements and underwritten public offerings. He advises clients in structuring and negotiating a wide variety of technology transactions, including patent, trademark, and copyright licenses, software and database licenses, stock and asset acquisition agreements, strategic alliances, joint ventures, collaboration agreements, sponsored research agreements, and materials transfer agreements. Richard also has substantial experience in the valuation, monetization and securitization of royalty streams and other intellectual property assets.
Before joining Mintz Levin, Richard was a senior attorney at the intellectual property law firm of Fish & Neave in New York City. He began his legal career with Brown & Wood, where he practiced in the Securities and Mergers and Acquisitions departments.
During law school, he was Articles Editor for the Rutgers Law Journal.
Professional & Community Involvement
- Member, Licensing Executive Society
- Member, Intellectual Property Owners Association (IPO)
- Member, IPO Open Source Software Committee
- Member, American Intellectual Property Law Association (AIPLA)
- Member, AIPLA Patent Misuse and Antitrust Committee
- Member, New York Intellectual Property Law Association (NYIPLA)
- Member, NYIPLA Litigation Committee
Richard advises clients on all aspects of intellectual property litigation, including patent, copyright, trademark, and trade secret litigation and related antitrust and unfair competition matters. He has represented numerous Fortune 100 companies in intellectual property infringement cases nationwide.
A registered patent attorney, Richard regularly counsels companies in the development and protection of their intellectual property portfolios, with a particular emphasis on computer software, medical devices and diagnostics, and he provides advice on intellectual property strategy in general. He also provides patentability, non-infringement, and invalidity opinions in a variety of technology areas and serves on Mintz Levin's Opinion Committee.
Richard has extensive experience performing intellectual property audits and due diligence for high tech and life sciences companies and investors in connection with various commercial transactions, including mergers and acquisitions, private placements and underwritten public offerings. He advises clients in structuring and negotiating a wide variety of technology transactions, including patent, trademark, and copyright licenses, software and database licenses, stock and asset acquisition agreements, strategic alliances, joint ventures, collaboration agreements, sponsored research agreements, and materials transfer agreements. Richard also has substantial experience in the valuation, monetization and securitization of royalty streams and other intellectual property assets.
Before joining Mintz Levin, Richard was a senior attorney at the intellectual property law firm of Fish & Neave in New York City. He began his legal career with Brown & Wood, where he practiced in the Securities and Mergers and Acquisitions departments.
During law school, he was Articles Editor for the Rutgers Law Journal.
Professional & Community Involvement
- Member, Licensing Executive Society
- Member, Intellectual Property Owners Association (IPO)
- Member, IPO Open Source Software Committee
- Member, American Intellectual Property Law Association (AIPLA)
- Member, AIPLA Patent Misuse and Antitrust Committee
- Member, New York Intellectual Property Law Association (NYIPLA)
- Member, NYIPLA Litigation Committee
Publications
-
Co-author,
U.S. Supreme Court Rules That Isolated Human Genes Are Unpatentable, Intellectual Property Alert ()
-
Co-author,
Patent Eligibility of Software Innovations After CLS Bank, Intellectual Property Advisory ()
-
Co-author,
Online Copyright Liability and Safe Harbors, New York Law Journal ()
-
Co-author,
The Kodak Bankruptcy: The Valuation and Sale of IP Assets, The Bankruptcy Strategist ()
-
Co-author,
Supreme Court Invalidates Biotech Method Patent in Mayo v. Prometheus, Intellectual Property Alert ()
-
Co-author,
Federal Circuit Affirms ITC’s Extraterritorial Authority in Trade Secret Cases, Intellectual Property Alert ()
-
Co-author,
Invention Assignment Following Stanford v. Roche: Implications for Technology Transfer and Government Contracts, Energy & Clean Technology Alert ()
-
Co-author,
Invention Assignment Following Stanford v. Roche: Implications for Technology Transfer and Government Contracts, Life Sciences Alert ()
Speaking Engagements
-
Speaker,
A Discussion of the Supreme Court’s Mayo v. Prometheus Decision: Clarity or Confusion?,
Mintz Levin, Webinar
-
Chair,
Recent Developments in U.S. and European Patent La,
AdvaMed 2009,
AdvaMed
-
Speaker,
Israel Venture Network,
New York, NY
-
Moderator,
When Cash is King – Strategies and Trends for Royalty Monetization,
BIO CEO & Investor Conference, New York, NY
-
Moderator,
Recent Developments in Intellectual Property Law for MedTech Companies,
AdvaMed 2008 - The MedTech Conference, Washington, DC
Newsroom